[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS)

Upstate Institutional Review Board (IRB) Number:

1652327

Patient Age Group:

Adults

Principal Investigator:

Eufrosina I Young

Who can I contact for more information?

Name: Sigiriya E Smolen
Phone: 315-464-9767
Email: smolens@upstate.edu

Return to Previous Page || Search Again

Top